DC Devices

Headquartered in Cambridge, MA, DC Devices is developing the first transcatheter device for diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). The company’s proprietary and innovative IASD™ (InterAtrial Shunt Device) System is minimally invasive and is designed to relieve increased left atrial pressure (LAp), the main cause of DHF/HFpEF symptoms.